glp 1 celiac GLP-1 for People with Disease GLP-1 and GLP-2 Orchestrate Intestine

For complete step-by-step visual guides specific to each medication, see our dedicated reconstitution articles: how to reconstitute 5mg semaglutide , the full semaglutide reconstitution guide , and how to reconstitute tirzepatide

Patients who might be considered for GLP-1 therapy (within licensed indications) and who may experience secondary benefits for binge eating behaviours include: Individuals with binge eating disorder and type 2 diabetes , where GLP-1 agonists address the primary diabetes indication whilst potentially helping with eating patterns Those with BED and obesity who meet NHS eligibility criteria for weight management medications (as defined by NICE TA875 for semaglutide or TA664 for liraglutide, which are narrower than the marketing authorisation) Patients who have not responded adequately to psychological interventions such as cognitive behavioural therapy (CBT) and who have concurrent metabolic conditions Those experiencing significant food cravings and loss-of-control eating as part of their weight management challenges However, important cautions and considerations apply

Weight-loss medications should only be prescribed and monitored by qualified healthcare professionals

With the right tools, knowledge, and support, you can craft a life that feels aligned, enchanted, and full of possibility